Mellozzan

Melatonin, the active ingredient in Mellozzan, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia and jet lag in adults, particularly those experiencing difficulty falling asleep due to shift work or travel across time zones.

GNH USA supplies Mellozzan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mellozzan (melatonin) acts on the melatonin receptor pathway to facilitate sleep regulation.

Insomnia: supports faster sleep onset and may reduce the number of awakenings during the night, aiding adults who have difficulty initiating or maintaining sleep. Jet lag: assists in resetting the internal clock after rapid east‑west travel, promoting quicker adjustment to a new sleep‑wake schedule. Delayed sleep phase disorder: may advance sleep timing in individuals whose circadian rhythm is shifted later than desired.

Oral melatonin is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Drowsiness: feeling of sleepiness during daytime. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Hormonal effects: altered menstrual cycles in women.

When considering melatonin therapy, several precautionary measures should be observed.

Pregnancy: safety has not been established; use only if clearly needed. Breastfeeding: unknown effects; weigh benefits against potential risks. Pediatric use: not recommended without specialist guidance. Concomitant CNS depressants: may enhance sedative effect. Medical conditions: assess liver or kidney impairment before use. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Melatonin may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): melatonin can increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce drug levels.

Moderate Interactions (Monitor Closely): - Sedatives (benzodiazepines, antihistamines): additive sleepiness. - Antidepressants (SSRIs, MAO inhibitors): possible serotonin syndrome. - Caffeine or stimulants: may counteract melatonin’s sleep‑promoting effect.